Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Information Update - Health Canada warns about hand sanitizers that may pose health risks


OTTAWA, ON, April 20, 2022 /CNW/ - Health Canada is advising Canadians that the following hand sanitizers are being recalled because they may pose health risks. For more information, including what Canadians should do, visit the online safety alert.

Health Canada maintains this list of hand sanitizers that may pose health risks, so that Canadians can easily identify products they may have purchased and take appropriate action. Canadians are encouraged to check it regularly for updates.

Product

Health Risk

Company

NPN or
DIN

Lot
Number

Expiry Date

Action
Taken

Fighting Spirit

Contains undeclared impurity, acetaldehyde, at elevated levels

The Newfoundland Distillery Company

80097930

20136

47

53

54

55

2025-04

Product recalled by company

 

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 09:10
Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases
Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office regarding its patent application entitled "Stimulation of Mesenchymal Stem Cell Therapeutics...

at 09:07
Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN--Journal of the National Comprehensive Cancer Network
Daniel M. Geynisman, MD, is being announced as the new Editor-in-Chief for JNCCN?Journal of the National Comprehensive Cancer Network. Dr. Geynisman has a long history of working with NCCN in a variety of roles and served as medical oncology section...

at 09:05
Zephyr AI Announces the Appointment of John Applegate as its CFO
Zephyr AI, Inc., a high-growth healthcare technology company committed to developing artificial intelligence (AI) solutions to democratize precision medicine, has announced that veteran biotechnology executive John Applegate has joined the company as...

at 09:05
A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced dosing of the first patient in the Phase 1 clinical trial of A2B694. The multi-center...

at 09:05
CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results
CEL-SCI Corporation today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments. Clinical and Corporate Developments include: In May 2024, CEL-SCI received the go-ahead from...

at 09:02
New Survey by Understood.org Reveals Workplace Stigma for Neurodivergent Employees
Understood.org, a leading nonprofit empowering more than 70 million neurodivergent people who have learning and thinking differences, such as ADHD and dyslexia, today announced the results of a Harris Poll of over 2,000 U.S. adults ages 18+. The poll...

More news about Health...


News published on and distributed by: